• Phio Pharmaceuticals held its annual shareholder meeting on Sept. 28, 2026.
• Shareholders authorized an amendment to the 2020 long-term incentive plan, lifting the share reserve by 1,500,000 to 2,452,017.
• The authorization took effect upon shareholder approval; the filing does not confirm any awards have been issued under the expanded pool.
• Grant Thornton was ratified as independent registered public accounting firm for the year ending Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-031337), on September 28, 2026, and is solely responsible for the information contained therein.